Suchergebnisse - "Foer, Dinah"

PubPharm (45)

11

Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma : A target trial emulation

enthalten in: The Journal of allergy and clinical immunology | 2023

von Akenroye, A. | Segal, J. | Zhou, G. | +5

12

Glucagon-like peptide-1 receptor agonist use is associated with lower serum periostin

enthalten in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology | 2023

von Foer, D. | Beeler, P. | Cui, J. | +7

13

Utility of Hypoglycemic Agents to Treat Asthma with Comorbid Obesity

enthalten in: Pulmonary therapy | 2023

von Ge, D. | Foer, D. | Cahill, K.

14

Post-Acute COVID-19 Respiratory Symptoms in Patients With Asthma : An Electronic Health Records-Based Study

enthalten in: The journal of allergy and clinical immunology. In practice | 2023

von Wang, L. | Foer, D. | Zhang, Y. | +3

CommentIn: J Allergy Clin Immunol Pract. 2023 Oct;11(10):3284-3285. - PMID 37805230

15

Patient Characteristics Associated With Reactions to Mrgprx2-Activating Drugs in an Electronic Health Record-Linked Biobank

enthalten in: The journal of allergy and clinical immunology. In practice | 2023

von Foer, D. | Wien, M. | Karlson, E. | +3

16

Utility of Hypoglycemic Agents to Treat Asthma with Comorbid Obesity

enthalten in: Pulmonary therapy | 2022

von Ge, D. | Foer, D. | Cahill, K.

17

Utility of Hypoglycemic Agents to Treat Asthma with Comorbid Obesity

enthalten in: Pulmonary therapy | 2022

von Ge, D. | Foer, D. | Cahill, K.

18

Toward an asthma patient-reported outcome measure for use in digital remote monitoring

enthalten in: The Journal of asthma : official journal of the Association for the Care of Asthma | 2022

von Rudin, R. | Qureshi, N. | Foer, D. | +2

19

Glucagon-Like Peptide-1 Receptor Regulates Thromboxane-Induced Human Platelet Activation

enthalten in: JACC. Basic to translational science | 2022

von Cahill, K. | Amin, T. | Boutaud, O. | +14

20

Key use cases for artificial intelligence to reduce the frequency of adverse drug events : a scoping review

enthalten in: The Lancet. Digital health | 2022

von Syrowatka, A. | Song, W. | Amato, M. | +11